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Abstract: I n t r o d u c t i o n: Th e number of Foxp3+ lymphocytes is increased in patients with esopha-
geal carcinoma. Little is known about Foxp3+ cells count in Barret’s esophagus, which is a precancerous 
state for esophageal cancer.
A i m: To count the number of Foxp3+ lymphocytes in tissue samples from patients with Barrett’s and 
compare it with samples from individuals with esophagitis and esophageal cancer.
M a t e r i a l s  a n d  m e t h o d s: 43 patients were enrolled to the study: 14 with esophageal carcinoma, 
15 with Barrett’s esophagus and 14 with non-metaplastic esophagitis. Every patient undergone gastros-
copy during which a tissue sample was taken. Foxp3+ lymphocytes and CD4+ lymphocytes were detected 
by using immunohistochemistry.
R e s u l t s: Mean density of Foxp3+ cells in patients with esophagitis was 7.37/10HPF (range: 1–9), 
18.5/10HPF (range: 5–29) and 26.8/10HPF (range: 16–40) in patients with dysplastic and non-dysplastic 
BE, respectively and 47.92/10HPF in individuals with esophageal a carcinoma. Th ese intergroup diff er-
ences turned out to be statistically signifi cant (p = 0.000; Fig. 3). Patients, either with dysplasia or without, 
presented with signifi cantly higher Foxp3+ cell counts than the subjects with esophagitis (p = 0.0003 and 
p = 0.0006, respectively). Also the number of Foxp3+ lymphocytes in esophageal adenocarcinoma speci-
mens turned out to be signifi cantly higher than in esophagitis (p = 0.0001), non-dysplastic and dysplastic 
BE tissue (p = 0.016 and p = 0.00047, respectively). 
C o n c l u s i o n s: Barrett’s metaplasia, either with dysplasia or without, is associated with an evident 
increase in the number of Foxp3 lymphocytes within the esophagogastric junction mucosa. Restoration of 
lymphocyte balance in esophageal tissue might prevent malignant transformation of Barrett’s metaplasia.
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Introduction
Th e pathophysiology of Barrett’s esophagus (BE) is poorly understood. Th is condition is 
defi ned as a reparative metaplastic remodeling of the esophagogastric junction mucosa 
in response to chro nic infl ammation associated with refl ux disease. BE is an established 
risk factor for esophageal adenocarcinoma [1, 2]. During the course of BE, normal 
stratifi ed squamous epithelium of the esophagus is replaced by a cylindrical epithelium 
characteristic for lower gastrointestinal tract. Th is is considered to be a factor predispos-
ing to esophageal adenocarcinoma, a condition with particularly poor prognosis.
Only few previous studies dealt with the immunological aspects of BE pathogenesis. 
Th is condition is postulated to be primarily associated with the mechanisms of humoral 
immunity. Nevertheless, lymphocytic infi ltration of the metaplastic esophageal epithe-
lium has been observed as well. Some of the infi ltrating lymphocytes are the so-called 
T-regulatory cells (Tregs) with TCD4+CD25+Foxp3+ phenotype. Th is lymphocyte sub-
population is currently a subject of extensive research owing its involvement in carcino-
genesis. However, the available evidence is inconclusive. While Treg count in infl amed 
mucosa of patients with gastroesophageal refl ux disease was shown to be reduced [3], 
concentration of Foxp3+ lymphocytes in esophageal cancer tissue seems to be higher 
than in normal esophagus, and is even considered a prognostic factor [4]. Tregs pro-
mote carcinogenesis due to induction of local immunosuppression. However, we still do 
not know when exactly these cells start to accumulate within the altered tissue, and if 
they induce local immunosuppression already at early stages of carcinogenesis, thus en-
abling survival of cancer cells that would otherwise be recognized and destroyed by hu-
man immune system. Finally, it is unclear If Tregs play also a role in BE pathogenesis.
Objective
Th e aim of the study was to compare the density of Foxp3+ lymphocytes in biopsy 
specimens from Barrett’s glandular metaplasia, esophageal adenocarcinoma and 
infl amed non-metaplastic esophageal mucosa, in order to analyze the evolution of 
immune response at consecutive stages of the esophagogastric junction pathology.
Methods and material
Th e study included subjects with clinical or endoscopic indications for the esopha go-
gastric junction biopsy (suspected infl ammation or BE) and patients with esophageal 
carcinoma, all examined at the John Paul II Hospital in Krakow.
Individuals with a  history of previous anticancer treatment, confi rmed immu-
nodefi ciency or diabetes mellitus, as well as pregnant women, were excluded from 
the study. Written informed consent was sought from all the study subjects. Th e 
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protocol of the study was approved by the Local Bioethics Committee (decision no. 
KBET/288/B/2014).
Tregs were detected immunohistochemically (IHC) in paraffi  n-embedded tissue 
specimens. Selected paraffi  n blocks were cut into 4 μm-thick sections and mounted on 
glass slides. Th e slides were triple deparaffi  nized in three changes of xylene for 10 min, 
and dehydrated in ethanol gradient (70%, 86% and 96%, 5 min each). Th e activity of 
endogenous peroxidase was blocked by 10-min incubation with 3% H2O2. Subsequently, 
the slides were placed in EDTA buff er (pH 8.0, 0.01M) and heated for 30 min at a water 
bath (98°C) to unmask the epitopes. Th en, monoclonal mouse anti-human FOXP3 anti-
body (Abcam, 236A/E7, 1:100) was applied, and the slides were incubated at room tem-
perature for 30 min. Aft er washing off  the residual unbound antibody with TBS buff er 
(50 mM Tris-HCl, 150 mM NaCl, pH 7,6; DAKO Corp.), antigen-antibody complexes 
were visualized with Ultra Vision LP Value Detection System (Lab Vision Corp.) with 
3,3-diaminobenzidine tetrahydrochloride (DAB, DAKO Corp.) as a chromogen. Finally, 
cellular nuclei were counterstained with Mayer’s hematoxylin for 1 min, the slides were 
cover slipped and sealed with Cytoseal XYL (Th ermo SCIENTIFIC). Th e slides were 
examined under an Olympus CX41 microscope; the number of IHC-positively stained 
cells was determined in ten high-power fi elds (HPF, x 400) in the areas of greatest den-
sity. Th e density of Tregs was calculated as the mean absolute number of IHC-positively 
stained cells showing nuclear reaction to the anti-FOXP3+ antibody.
Statistical analysis was conducted with Statistica 12 package. Th e signifi cance of 
intergroup diff erences in Treg count was verifi ed with Mann-Whitney U-test and 
Kruskal-Wallis ANOVA.
Material
Th e study included 14 patients with esophageal carcinoma and 15 with BE; the latter 
group was divided into two subsets: with esophageal dysplasia (n = 9) and without 
(n = 6). Control group was comprised of 14 patients with non-metaplastic esophagi-
tis. Women constituted 42% of the study subjects. Median age of the participants was 
61.42 years (range: 32–83 years; Table 1).
Table 1. Patient characteristics.
Type of lesion Number of patients Mean age (range)
Mena density 
of Foxp3+ T cells (range)
Esophagitis 14 61.2 (40–83)  3.50 (1–9)
Non-dysplastic Barrett’s esophagus  9 61.7 (52–74) 26.75 (16–40)
Dysplastic Barrett’s esophagus  6 55.0 (32–80) 17.40 (5–29)
Esophageal cancer 14 65.0 (51–78) 47.90 (36–68)
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Results
All examined specimens contained Foxp3+ lymphocytes. Th e number of Tregs was 
not infl uenced by patient sex. Mean density of Foxp3+ cells was 7.37/10HPF (range: 
1–9; Fig. 1) in subjects with esophagitis, 18.5/10HPF (range: 5–29) and 26.8/10HPF 
(range: 16–40) in patients with dysplastic and non-dysplastic BE, respectively 
(Fig.  2), and 47.92/10HPF in individuals with esophageal a  carcinoma. Th ese inter-
group diff erences turned out to be statistically signifi cant (p = 0.000; Fig. 3). Post-
hoc analysis demonstrated that BE patients, either with dysplasia or without, pre-
sented with signifi cantly higher Foxp3+ cell counts than the subjects with esophagitis 
(p = 0.0003 and p = 0.0006, respectively). Also the number of Foxp3+ lymphocytes 
in esophageal adenocarcinoma specimens turned out to be signifi cantly higher than 
in esophagitis (p = 0.0001), non-dysplastic and dysplastic BE tissue (p = 0.016 and 
p = 0.00047, respectively). No statistically signifi cant diff erences in Foxp3+ cell counts 
were found between the subsets of patients with dysplastic and non-dysplastic BE 
(p = 0.12). 
Fig. 1. Foxp3+ T cells in infl amed esophageal mucosa.
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Fig. 2. Foxp3+ T cells in a biopsy specimen of dysplastic Barrett’s esophagus.
Fig. 3. Density of Foxp3+ T cells, stratifi ed according to the type of lesion (1 — esophagitis, 2 — non-
dysplastic Barrett’s esophagus, 3 — dysplastic Barrett’s esophagus, 4 — esophageal cancer).
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Discussion
Glandular metaplasia of esophageal mucosa is postulated to be a  potent risk factor 
for malignant transformation [5]. Previous studies demonstrated that lymphocytic 
infi ltration is present already at early stages of both esophagitis and Barrett’s 
metaplasia [6]. Contrary to the infl ammatory lesions, whereby the key role is played 
by Th 1 cells, a  shift  toward Th 2-mediated immune response is observed during the 
course of progression to BE, which results in the synthesis of pro-infl ammatory 
cytokines [7].
Also dendritic cells are implicated in the etiopathogenesis of BE. Th e accumulation 
of these cells has been observed in biopsy specimens from the esophagogastric 
junction of patients with established Barrett’s metaplasia [8]. Moreover, dendritic 
stem cells co-cultured with esophageal adenocarcinoma and BE cell lines with various 
degree of dysplasia were shown to stimulate the diff erentiation of Foxp3+ Tregs from 
“naive” CD4+ T cells [9].
To the best of our knowledge, the present study is the fi rst to demonstrate that 
the number of Tregs in esophageal mucosa increases substantially already at the stage 
of Barrett’s metaplasia. Th is implies that BE may represent an early stage of local 
immunosuppression and some its underlying processes may resemble those taking 
place within the invasive cancer tissue. 
Previous studies demonstrated with the level of Tregs in peripheral blood of 
patients with esophageal cancer is higher than healthy persons [10]. Moreover, the 
distribution of T cells is known to change with the progression of infl ammatory 
lesions to Barrett’s metaplasia and then to esophageal cancer. Specifi cally, an increase 
in the amount of ‘naïve’ CD7+ cells and a  concomitant decrease in the number of 
CD4+ and NK cells are observed within the esophageal tissue [6].
Wang et al. demonstrated that the density of Foxp3+ lymphocytes infi ltrating 
the tumor correlates positively with the level of anti-infl ammatory interleukin 10, 
thus contributing to immunosuppression. The same study showed that patients 
with greater density of Tregs are more prone to develop synchronous malig-
nancies [11].
Recently, Li et al. revealed that the so-called tumor-derived microvesicles may 
induce formation of B-regulatory cells that can suppress proliferation of cytotoxic 
CD8 T lymphocytes [12]. A transmission electron microscopic study demonstrated 
the presence of similar microvesicles in normal esophagus, and showed that their 
number increases during the course of metaplasia-dysplasia-adenocarcinoma 
sequence [13].
Functional suppression of Tregs is a  subject of ongoing research as a  potential 
method to improve the treatment outcomes in patients with esophageal dysplasia. 
Reginato et al. analyzed the effects of photodynamic therapy (PDT), a  method 
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for ablation of esophageal dysplasia, on the activity of Tregs. While an increase in 
peripheral neutrophil count and serum level of interleukin-6 has been observed at 
7 days post-PDT, the number of Tregs remained unchanged which likely corresponded 
to their functional suppression [14].
Th e eff ect of BE treatment on lymphocyte balance is still unclear. Th e results of 
previous studies point to argon plasma coagulation (APC) of metaplastic epithelium 
as a  promising therapeutic option in BE [15]. Since the underlying mechanisms of 
BE and esophageal adenocarcinoma likely overlap, future research should center 
around the restoration of lymphocyte balance during the course of APC and other 
ablative therapies, such as HALO and PDT. Importantly, APC was already shown to 
reduce the overexpression of cyclooxygenase-2 (COX2) within the esophagogastric 
junction, another factor involved in BE etiopathogenesis [16]. In view of this 
promising preliminary evidence, a  study of APC-induced changes in the number 
of Tregs in biopsy specimens from patients with BE is currently conducted at 
our clinic.
Conclusions
Barrett’s metaplasia, either with dysplasia or without, is associated with an evident in-
crease in the number of Foxp3 lymphocytes within the esophagogastric junction mu-
cosa. Restoration of lymphocyte balance in esophageal tissue might prevent malignant 
transformation of Barrett’s metaplasia.
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